About Cantel Medical Corp. (NYSE:CMD)
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.
Industry, Sector and Symbol:
- Industry: Medical Equipment Wholesale
- Sub-Industry: N/A
- Sector: Medical Equipment Wholesale
- Symbol: NYSE:CMD
- CUSIP: N/A
- Web: www.cantelmedical.com
- Debt-to-Equity Ratio: 0.24%
- Current Ratio: 2.41%
- Quick Ratio: 1.49%
Sales & Book Value:
- Trailing P/E Ratio: 48.42
- Forward P/E Ratio: 44.29
- Annual Sales: $770.16 million
- Price / Sales: 5.62
- Cash Flow: $2.97 per share
- Price / Cash: 34.85
- Book Value: $12.56 per share
- Price / Book: 8.25
- Annual Dividend: $0.14
- Dividend Yield: 0.1%
- Trailing EPS: $1.71
- Net Income: $71.37 million
- Net Margins: 9.27%
- Return on Equity: 17.60%
- Return on Assets: 11.29%
- Employees: 2,337
- Outstanding Shares: 41,730,000
Frequently Asked Questions for Cantel Medical Corp. (NYSE:CMD)
What is Cantel Medical Corp.'s stock symbol?
Cantel Medical Corp. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."
How often does Cantel Medical Corp. pay dividends? What is the dividend yield for Cantel Medical Corp.?
Cantel Medical Corp. declared a Semi-Annual dividend on Wednesday, November 1st. Shareholders of record on Wednesday, January 17th will be given a dividend of $0.085 per share on Wednesday, January 31st. This represents a yield of 0.17%. The ex-dividend date is Tuesday, January 16th. This is a boost from Cantel Medical Corp.'s previous Semi-Annual dividend of $0.07. View Cantel Medical Corp.'s Dividend History.
How were Cantel Medical Corp.'s earnings last quarter?
Cantel Medical Corp. (NYSE:CMD) released its earnings results on Thursday, September, 28th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.52 by $0.02. The business had revenue of $205.50 million for the quarter, compared to analysts' expectations of $200.32 million. Cantel Medical Corp. had a return on equity of 17.60% and a net margin of 9.27%. The company's revenue for the quarter was up 14.8% on a year-over-year basis. View Cantel Medical Corp.'s Earnings History.
When will Cantel Medical Corp. make its next earnings announcement?
Where is Cantel Medical Corp.'s stock going? Where will Cantel Medical Corp.'s stock price be in 2017?
4 Wall Street analysts have issued twelve-month price objectives for Cantel Medical Corp.'s stock. Their forecasts range from $92.00 to $100.00. On average, they anticipate Cantel Medical Corp.'s share price to reach $96.00 in the next year. View Analyst Ratings for Cantel Medical Corp..
What are Wall Street analysts saying about Cantel Medical Corp. stock?
Here are some recent quotes from research analysts about Cantel Medical Corp. stock:
- 1. According to Zacks Investment Research, "Cantel Medical Corp. is a healthcare company concentrating primarily in infection prevention and control products and diagnostic and therapeutic medical equipment. Through its United States subsidiary, MediVators, Inc., Cantel serves customers worldwide by designing, developing, manufacturing, marketing and distributing innovative products for the infection prevention and control industry. " (8/8/2017)
- 2. Needham & Company LLC analysts commented, "CMD’s F3Q17 revenue and EPS met consensus. Overall organic revenue growth slowed to 7.4% CC in F3Q17 from 12.1% CC in F2Q17 due mainly to a difficult comp. Endoscopy growth slowed from F2Q17 as expected; its 9% growth was just below our 10% estimate but we consider this to be a solid result considering that CMD was up against a 44% comp in F3Q16 (driven, in part, by the Custom Ultrasonics recall). Water Purification & Filtration and Healthcare Disposables growth also slowed from F2Q17. Adjusted gross margin was up 130 bps Y/Y due to product mix and cost improvements and this marked the 14th consecutive quarter of Y/ Y gross margin improvement. We maintain our Hold given CMD’s slower organic growth and valuation (CY17E P/E of 35.7x vs. small/mid-cap GARP peers at 27.9x)." (6/8/2017)
Are investors shorting Cantel Medical Corp.?
Cantel Medical Corp. saw a decline in short interest in October. As of October 13th, there was short interest totalling 798,587 shares, a decline of 32.0% from the September 29th total of 1,175,114 shares. Based on an average daily trading volume, of 222,726 shares, the days-to-cover ratio is presently 3.6 days.
Who are some of Cantel Medical Corp.'s key competitors?
Some companies that are related to Cantel Medical Corp. include CPFL Energia S.A. (CPL), Zayo Group Holdings (ZAYO), Alleghany Corporation (Y), Teradyne (TER), Veeva Systems (VEEV), Hyatt Hotels Corporation (H), Camden Property Trust (CPT), Michael Kors Holdings Limited (KORS), CF Industries Holdings (CF), ManpowerGroup (MAN), LATAM Airlines Group S.A. (LTM), MeadWestvaco Corp. (MWV), GoDaddy (GDDY), UGI Corporation (UGI), Vistra Energy Corp. (VST), Repsol Oil & Gas Canada (TLM), Kimco Realty Corporation (KIM) and Mosaic Company (The) (MOS).
Who are Cantel Medical Corp.'s key executives?
Cantel Medical Corp.'s management team includes the folowing people:
- Charles M. Diker, Chairman of the Board (Age 82)
- Jorgen B. Hansen, President, Chief Executive Officer, Director (Age 49)
- Peter G. Clifford, Chief Financial Officer, Executive Vice President (Age 46)
- Eric W. Nodiff, Executive Vice President, General Counsel, Secretary (Age 59)
- Seth M. Yellin, Executive Vice President - Strategy and Corporate Development (Age 42)
- Brian Capone, Principal Accounting Officer, Vice President, Corporate Controller (Age 42)
- Mark N. Diker, Director (Age 50)
- Peter J. Pronovost M.D. Ph.D., Director (Age 52)
- Alan R. Batkin, Presiding Independent Director (Age 72)
- Ann E. Berman CPA, Independent Director (Age 64)
Who owns Cantel Medical Corp. stock?
Cantel Medical Corp.'s stock is owned by a number of of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (2.34%), Wells Fargo & Company MN (2.03%), Conestoga Capital Advisors LLC (1.77%), Pictet Asset Management Ltd. (1.69%), Wasatch Advisors Inc. (1.29%) and Bank of New York Mellon Corp (1.14%). Company insiders that own Cantel Medical Corp. stock include Anthony B Evnin, Charles M Diker, Eric W Nodiff, George L Fotiades and Mark N Diker. View Institutional Ownership Trends for Cantel Medical Corp..
Who sold Cantel Medical Corp. stock? Who is selling Cantel Medical Corp. stock?
Cantel Medical Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Zurcher Kantonalbank Zurich Cantonalbank, Prudential Financial Inc., Bank of New York Mellon Corp, Ameriprise Financial Inc., Advisors Asset Management Inc., Gamco Investors INC. ET AL and Eagle Asset Management Inc.. Company insiders that have sold Cantel Medical Corp. company stock in the last year include Charles M Diker, Eric W Nodiff, George L Fotiades and Mark N Diker. View Insider Buying and Selling for Cantel Medical Corp..
Who bought Cantel Medical Corp. stock? Who is buying Cantel Medical Corp. stock?
Cantel Medical Corp.'s stock was purchased by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., Wasatch Advisors Inc., Westfield Capital Management Co. LP, Dynamic Technology Lab Private Ltd, Conestoga Capital Advisors LLC, Crossmark Global Holdings Inc., Los Angeles Capital Management & Equity Research Inc. and Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Cantel Medical Corp..
How do I buy Cantel Medical Corp. stock?
Shares of Cantel Medical Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cantel Medical Corp.'s stock price today?
One share of Cantel Medical Corp. stock can currently be purchased for approximately $103.65.
How big of a company is Cantel Medical Corp.?
Cantel Medical Corp. has a market capitalization of $4.34 billion and generates $770.16 million in revenue each year. The company earns $71.37 million in net income (profit) each year or $1.71 on an earnings per share basis. Cantel Medical Corp. employs 2,337 workers across the globe.
How can I contact Cantel Medical Corp.?
Cantel Medical Corp.'s mailing address is 150 Clove Rd, LITTLE FALLS, NJ 07424-2138, United States. The company can be reached via phone at +1-973-8907220 or via email at [email protected]
MarketBeat Community Rating for Cantel Medical Corp. (NYSE CMD)MarketBeat's community ratings are surveys of what our community members think about Cantel Medical Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Cantel Medical Corp. (NYSE:CMD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 3 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.25)|
|Consensus Price Target: ||$96.00 (7.38% downside)|
Consensus Price Target History for Cantel Medical Corp. (NYSE:CMD)
Analysts' Ratings History for Cantel Medical Corp. (NYSE:CMD)
(Data available from 11/18/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/1/2017||Needham & Company LLC||Reiterated Rating||Hold||Medium|
|8/2/2017||Sidoti||Upgrade||Neutral -> Buy||$92.00||High|
|6/9/2017||Benchmark Co.||Downgrade||Buy -> Hold||High|
|3/17/2017||Raymond James Financial, Inc.||Initiated Coverage||Mkt Perform -> Market Perform||Low|
Earnings History and Estimates Chart for Cantel Medical Corp. (NYSE:CMD)
Earnings History by Quarter for Cantel Medical Corp. (NYSE CMD)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|9/28/2017||Q4 2017||$0.52||$0.54||$200.32 million||$205.50 million||View||N/A|
|6/8/2017||Q3 2017||$0.51||$0.51||$193.84 million||$192.10 million||View||Listen|
|3/9/2017||1/31/2017||$0.50||$0.52||$189.58 million||$184.80 million||View||Listen|
|12/8/2016||Q1 2017||$0.48||$0.51||$183.44 million||$187.70 million||View||N/A|
Earnings Estimates for Cantel Medical Corp. (NYSE:CMD)
Current Year EPS Consensus Estimate: $2.34 EPS
Next Year EPS Consensus Estimate: $2.65 EPS
Current Dividend Information for Cantel Medical Corp. (NYSE:CMD)
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||8.19% (Trailing 12 Months of Earnings) |
5.98% (Based on This Year's Estimates)
5.28% (Based on Next Year's Estimates)
Dividend History by Quarter for Cantel Medical Corp. (NYSE CMD)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Cantel Medical Corp. (NYSE CMD)
Insider Ownership Percentage: 14.90%
Institutional Ownership Percentage: 85.16%
Insider Trades by Quarter for Cantel Medical Corp. (NYSE CMD)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/20/2017||Eric W Nodiff||EVP||Sell||2,868||$97.55||$279,773.40|| |
|10/13/2017||George L Fotiades||Director||Sell||6,000||$95.23||$571,380.00|| |
|10/4/2017||Charles M Diker||Chairman||Sell||20,500||$99.15||$2,032,575.00|| |
|10/3/2017||Mark N Diker||Director||Sell||7,000||$98.90||$692,300.00|| |
|7/12/2017||Charles M Diker||Chairman||Sell||35,000||$75.52||$2,643,200.00|| |
|6/12/2017||Charles M Diker||Chairman||Sell||13,000||$76.36||$992,680.00|| |
|4/7/2017||Eric W Nodiff||EVP||Sell||1,500||$74.18||$111,270.00|| |
|3/15/2017||Anthony B Evnin||Director||Buy||2,500||$77.88||$194,700.00|| |
|1/19/2017||Eric W Nodiff||EVP||Sell||1,117||$76.68||$85,651.56|| |
|1/18/2017||Anthony B Evnin||Director||Buy||2,000||$76.26||$152,520.00|| |
Headline Trends for Cantel Medical Corp. (NYSE:CMD)
Latest Headlines for Cantel Medical Corp. (NYSE CMD)
|Cantel Medical (CMD) Presents At Jefferies 2017 London Healthcare Conference - Slideshow|
seekingalpha.com - November 17 at 9:33 PM
|No. 1-Ranked Medical Stock Near Breakout With Earnings Due|
finance.yahoo.com - November 13 at 10:39 PM
|Zacks: Cantel Medical Corp. (CMD) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - November 12 at 5:46 AM
|ETFs with exposure to Cantel Medical Corp. : November 9, 2017|
finance.yahoo.com - November 9 at 8:12 PM
|Cantel Medical to Present at the Jefferies 2017 London Healthcare Conference|
finance.yahoo.com - November 2 at 6:12 PM
|Cantel Medical Corp. (CMD) Announces Semi-Annual Dividend of $0.09|
www.americanbankingnews.com - November 2 at 11:52 AM
|Cantel Medical Announces 21% Increase In Semiannual Dividend|
finance.yahoo.com - November 1 at 6:09 PM
|Cantel Medical Corp. (CMD) Short Interest Update|
www.americanbankingnews.com - November 1 at 2:40 AM
| Cantel Medical Corp. (CMD) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - October 28 at 5:30 PM
|Eric W. Nodiff Sells 2,868 Shares of Cantel Medical Corp. (CMD) Stock|
www.americanbankingnews.com - October 23 at 7:28 PM
|Zacks: Cantel Medical Corp. (CMD) Receives Average Recommendation of "Hold" from Brokerages|
www.americanbankingnews.com - October 21 at 4:24 AM
|Cantel Medical Corp. (CMD) Director Sells $571,380.00 in Stock|
www.americanbankingnews.com - October 17 at 1:16 PM
|ETFs with exposure to Cantel Medical Corp. : October 16, 2017|
finance.yahoo.com - October 16 at 6:05 PM
|Pro-Trader Daily: Earnings Review and Free Research Report: Cantel Medical's Adjusted EPS Increased 12.5%|
www.finanznachrichten.de - October 10 at 11:35 PM
|Earnings Review and Free Research Report: Cantel Medical’s Adjusted EPS Increased 12.5%|
finance.yahoo.com - October 10 at 6:32 PM
|Mark N. Diker Sells 7,000 Shares of Cantel Medical Corp. (CMD) Stock|
www.americanbankingnews.com - October 5 at 1:29 PM
|Cantel Medical Corp. (CMD) Chairman Sells $2,032,575.00 in Stock|
www.americanbankingnews.com - October 4 at 7:20 PM
|ETFs with exposure to Cantel Medical Corp. : October 3, 2017|
finance.yahoo.com - October 3 at 5:09 PM
|Cantel Medical Corp. :CMD-US: Earnings Analysis: Q4, 2017 By the Numbers : October 2, 2017|
finance.yahoo.com - October 2 at 5:34 PM
|Cantel Medical Corp. Closes Out the Year With a Solid Mix of Growth|
finance.yahoo.com - October 2 at 5:34 PM
|Brokerages Anticipate Cantel Medical Corp. (CMD) to Post $0.52 EPS|
www.americanbankingnews.com - October 1 at 10:40 AM
|Cantel Medical Reports Record Financial Results For The Fourth Quarter Ended July 31, 2017 - PR Newswire (press release)|
www.prnewswire.com - September 30 at 3:28 PM
|Earnings Scheduled For September 28, 2017 - Benzinga|
www.benzinga.com - September 28 at 10:16 PM
|Cantel's (CMD) CEO Jorgen Hansen on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha|
seekingalpha.com - September 28 at 10:16 PM
|Investor Network: Cantel Medical Corp. to Host Earnings Call|
www.baystreet.ca - September 28 at 5:12 PM
|Cantel Medical Corp. (CMD) Releases Earnings Results|
www.americanbankingnews.com - September 28 at 9:30 AM
|Pre-Market Earnings Report for September 28, 2017 : ACN, CAG, MKC, MTN, CMD, RAD, ANGO, FGP, OMN, HHS - Nasdaq|
www.nasdaq.com - September 27 at 7:21 PM
|Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter and Fiscal Year Ended July 31, 2017|
finance.yahoo.com - September 21 at 10:28 AM
|Cantel Medical Corp. (CMD) to Release Quarterly Earnings on Thursday|
www.americanbankingnews.com - September 21 at 1:22 AM
|Stocks With Rising Relative Strength: Cantel Medical|
finance.yahoo.com - September 20 at 6:06 PM
|This Medical Device Maker Is Now Outperforming 96% Of All Stocks|
finance.yahoo.com - September 18 at 5:19 PM
| Cantel Medical Corp. (CMD) Receives Consensus Recommendation of "Buy" from Analysts|
www.americanbankingnews.com - September 16 at 12:12 AM
|Needham & Company LLC Reaffirms Hold Rating for Cantel Medical Corp. (CMD)|
www.americanbankingnews.com - September 4 at 10:38 PM
|Cantel Medical Breaks Above 200-Day Moving Average - Bullish for CMD|
www.nasdaq.com - August 23 at 3:59 AM
| Cantel Medical Corp. (CMD) Given Consensus Recommendation of "Buy" by Analysts|
www.americanbankingnews.com - August 22 at 10:24 PM
|Cantel Medical Corp. breached its 50 day moving average in a Bearish Manner : CMD-US : August 18, 2017|
finance.yahoo.com - August 18 at 5:25 PM
|See what the IHS Markit Score report has to say about Cantel Medical Corp.|
finance.yahoo.com - August 13 at 2:54 AM
|Contrasting Cantel Medical Corp. (NYSE:CMD) and Owens & Minor (OMI)|
www.americanbankingnews.com - August 9 at 7:24 AM
|Cantel Medical Corp. breached its 50 day moving average in a Bullish Manner : CMD-US : August 7, 2017|
finance.yahoo.com - August 7 at 5:42 PM
|Cantel Medical (CMD) to Acquire BHT Group in Germany for $60.8M|
www.streetinsider.com - August 2 at 6:06 PM
|Cantel Medical to Acquire BHT Group in Germany|
finance.yahoo.com - July 31 at 5:12 PM
|Financial Analysis: Henry Schein (HSIC) & Cantel Medical Corp. (CMD)|
www.americanbankingnews.com - July 26 at 6:28 PM
|Comparing Henry Schein (HSIC) and Cantel Medical Corp. (CMD)|
www.americanbankingnews.com - July 25 at 9:20 AM
|Cantel Medical Corp. (NYSE:CMD) Chairman Sells $2,643,200.00 in Stock|
www.americanbankingnews.com - July 12 at 7:53 PM
|Analyzing Henry Schein (HSIC) & Cantel Medical Corp. (NYSE:CMD)|
www.americanbankingnews.com - July 12 at 6:28 PM
|Analyzing Cantel Medical Corp. (NYSE:CMD) and Owens & Minor (OMI)|
www.americanbankingnews.com - July 11 at 6:22 PM
|Ex-Dividend Reminder: Hormel Foods, Cantel Medical and PNC Financial Services Group|
www.nasdaq.com - July 11 at 6:22 PM
|Cantel Medical Corp. – Value Analysis (NYSE:CMD) : July 10, 2017|
finance.yahoo.com - July 10 at 5:16 PM
|Cantel Medical Corp. breached its 50 day moving average in a Bearish Manner : CMD-US : July 7, 2017|
finance.yahoo.com - July 8 at 9:51 AM
|Cantel Medical (CMD) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow|
seekingalpha.com - June 13 at 12:37 PM
Cantel Medical Corp. (NYSE CMD) Chart for Saturday, November, 18, 2017